Advertisement
Advertisement
TOI
The Oncology Institute, Inc. Common Stock
4.00
USDSponsored
-0.07
-1.72%
May 08, 16:00 UTC -4
Closed
After-Market
4.00
0.00
+0.12%
TOI Earnings Reports
Positive Surprise Ratio
TOI beat 2 of 12 last estimates.
17%
Next Report
Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
$157.43M
/-$0.06
Implied change from Q1 26 (Revenue/ EPS)
+6.77%
/+200.00%
Implied change from Q2 25 (Revenue/ EPS)
+31.41%
/-60.00%
The Oncology Institute, Inc. Common Stock earnings per share and revenue
On May 07, 2026, TOI reported earnings of -0.02 USD per share (EPS) for Q1 26, beating the estimate of -0.07 USD, resulting in a 74.46% surprise. Revenue reached 147.44 million, compared to an expected 144.67 million, with a 1.92% difference. The market reacted with a -1.72% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 157.43 million USD, implying an increase of 200.00% EPS, and increase of 6.77% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Establishment Labs Holdings Inc.
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.35
Actual
-$0.40
Surprise
-12.80%
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
LifeMD, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.20
Surprise
+12.85%
SkinHealth Systems Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.05
Surprise
+36.47%
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
Concentra Group Holdings Parent, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.34
Actual
$0.40
Surprise
+17.03%
FAQ
What were The Oncology Institute, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, The Oncology Institute, Inc. Common Stock reported EPS of -$0.02, beating estimates by 74.46%, and revenue of $147.44M, 1.92% above expectations.
How did the market react to The Oncology Institute, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -1.72%, changed from $4.07 before the earnings release to $4.00 the day after.
When is The Oncology Institute, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 11, 2026.
What are the forecasts for The Oncology Institute, Inc. Common Stock's next earnings report?
Based on 4
analysts, The Oncology Institute, Inc. Common Stock is expected to report EPS of -$0.06 and revenue of $157.43M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement